Subsequent-generation sequencing (NGS) has led a revolution within the analysis of genome construction and performance.
The price of NGS is getting cheaper resulting from competitors and technological innovation within the area, resulting in a rise within the utilization of NGS in healthcare amenities.
Based on GlobalData Premium SKU merchandise, the gross sales of main product strains of NGS options within the US elevated greater than 40% from 2021 to 2022, and the expansion stays sturdy in 2023.
The price of sequencing has considerably decreased over time resulting from rising competitors and advancing know-how.
The worth of sequencing a single genome was $100m in 2001. The associated fee has steadily decreased because the introduction of NGS, whatever the platform kind or know-how.
Main NGS platform gamers like Illumina and Life Applied sciences have claimed that entire genomes can now be sequenced for lower than $1,000 utilizing their platforms.
Entry essentially the most complete Firm Profiles
available on the market, powered by GlobalData. Save hours of analysis. Acquire aggressive edge.
Firm Profile – free
Your obtain e mail will arrive shortly
We’re assured concerning the
high quality of our Firm Profiles. Nevertheless, we would like you to take advantage of
choice for what you are promoting, so we provide a free pattern that you may obtain by
submitting the beneath type
General, sequencing prices have largely stabilised and high-throughput platforms have turn out to be extensively obtainable, leading to a broader use of whole-genome sequencing for oncology.
The commercialisation of recent sequencing applied sciences similar to DNBSEQ-T20×2, has additional contributed to the price discount in order that it now prices lower than $100m to sequence the entire human genome.
Quite a few corporations are capitalising on the necessity for personalised remedies by offering totally different NGS applied sciences similar to sequencing by synthesis and sequencing by ligation.
The rising and diversifying use of focused therapies, particularly together with one another, is prone to enhance NGS utilization because the trade strikes away from simply testing for single mutations.
Extra lately based corporations are utilising NGS know-how for direct-to-consumer (DTC) genetic testing, both by means of focused evaluation or whole-exome sequencing.
The lowering price of genetic testing has contributed to the elevated adoption of personalised drugs.
As the price of testing decreases, extra healthcare suppliers and sufferers are keen to include genetic testing into their medical care.
This has led to progress within the quantity of genetic checks being carried out. With reasonably priced genetic testing, healthcare suppliers can acquire insights into an individual’s distinctive genetic make-up, which might play a extra essential function within the apply of medication.
Personalised drugs goals to tailor medical remedies and interventions to a person’s genetic profile, resulting in extra focused and efficient healthcare.